Description
GLP2-T
GLP2-T — Research Dual Incretin Agonist (GLP-1 / GIP) – 10 MG
GLP2-TRZ is a research-use-only peptide analog designed to interact with glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor pathways. It is supplied exclusively for non-clinical laboratory research focused on dual-incretin signaling and metabolic pathway investigation.
Research Focus (Non-Clinical):
- Dual-receptor pathway modeling involving GLP-1R and GIPR signaling synergy
- Metabolic research models evaluating glucose regulation and energy balance pathways
- Exploratory combination research strategies involving incretin-pathway agents
Notes for Investigators:
This compound is intended for controlled laboratory research examining multi-hormonal modulation of metabolic signaling pathways. Public-facing materials intentionally avoid clinical or therapeutic positioning.
Regulatory & Use:
- For laboratory research use only
- Not a drug, food, cosmetic, or medical device
- Not for human or veterinary use
- No therapeutic, diagnostic, or dosing claims are made
